Standout Papers
Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Brandon Arnieri being referenced
Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint
2018
382 Phase Ib study of oral dual-PI3K/mTOR inhibitor GDC-0980 in combination with capecitabine and mFOLFOX6 + bevacizumab in patients with advanced solid tumors and colorectal cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Brandon Arnieri | 134 | 168 | 87 | 111 | 10 | 458 | |
| Melissa D. Curtis | 214 | 255 | 76 | 49 | 8 | 414 | |
| Ellie Siden | 59 | 79 | 107 | 102 | 12 | 475 | |
| Melisa Tucker | 297 | 350 | 118 | 70 | 13 | 549 | |
| Gwynn Ison | 88 | 208 | 97 | 68 | 16 | 416 | |
| Andrae Vandross | 78 | 102 | 67 | 89 | 18 | 529 | |
| Tracy Lively | 120 | 141 | 248 | 69 | 17 | 570 | |
| Alastair Matheson | 55 | 95 | 75 | 86 | 14 | 447 | |
| Travis Osterman | 55 | 117 | 59 | 17 | 31 | 463 | |
| Tiago M. de Carvalho | 271 | 287 | 24 | 24 | 14 | 515 | |
| Angela K. Green | 73 | 166 | 90 | 28 | 22 | 486 |
All Works
Loading papers...